Good clinical response to erlotinib in a patient with anaplastic thyroid carcinoma harboring an epidermal growth factor somatic mutation, L858R, in exon 21

Katsuhiro Masago; Masako Miura; Yoshiro Toyama; Yosuke Togashi; Michiaki Mishima

doi:10.1200/JCO.2010.34.0216

Good clinical response to erlotinib in a patient with anaplastic thyroid carcinoma harboring an epidermal growth factor somatic mutation, L858R, in exon 21

Katsuhiro Masago, Masako Miura, Yoshiro Toyama, Yosuke Togashi, Michiaki Mishima

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	e465-e467
Journal	Journal of Clinical Oncology
Volume	29
Issue number	16
DOIs	https://doi.org/10.1200/JCO.2010.34.0216
Publication status	Published - Jun 1 2011
Externally published	Yes

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/JCO.2010.34.0216

Cite this

@article{07338b5905084c63a576c6bfcc9f64d3,

title = "Good clinical response to erlotinib in a patient with anaplastic thyroid carcinoma harboring an epidermal growth factor somatic mutation, L858R, in exon 21",

author = "Katsuhiro Masago and Masako Miura and Yoshiro Toyama and Yosuke Togashi and Michiaki Mishima",

year = "2011",

month = jun,

day = "1",

doi = "10.1200/JCO.2010.34.0216",

language = "English",

volume = "29",

pages = "e465--e467",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "16",

}

TY - JOUR

T1 - Good clinical response to erlotinib in a patient with anaplastic thyroid carcinoma harboring an epidermal growth factor somatic mutation, L858R, in exon 21

AU - Masago, Katsuhiro

AU - Miura, Masako

AU - Toyama, Yoshiro

AU - Togashi, Yosuke

AU - Mishima, Michiaki

PY - 2011/6/1

Y1 - 2011/6/1

UR - http://www.scopus.com/inward/record.url?scp=79957939913&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957939913&partnerID=8YFLogxK

U2 - 10.1200/JCO.2010.34.0216

DO - 10.1200/JCO.2010.34.0216

M3 - Article

C2 - 21422425

AN - SCOPUS:79957939913

SN - 0732-183X

VL - 29

SP - e465-e467

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 16

ER -

Good clinical response to erlotinib in a patient with anaplastic thyroid carcinoma harboring an epidermal growth factor somatic mutation, L858R, in exon 21

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this